{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:15:03Z","timestamp":1788776103257,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Both spinal muscular atrophy (SMA) and Phenylketonuria (PKU) are caused by biallelic pathogenic mutations. However, there has been no report on case who suffering from both diseases simultaneously. SMA mainly affects the motor function while PKU may have an impact on both the intelligence and motor function. But if only 1 disease is treated while neglecting the other, the treatment effect will be compromised. Here, for the first time, we report a case from China diagnosed with both these diseases and treated properly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A boy was admitted to the Children\u2019s Hospital Affiliated to Shandong University (Jinan, China) due to \u201climb weakness for 19 months\u201d when he was 22 months old. Considering that the child\u2019s motor function development is delayed, we made a comprehensive examinations including inherited metabolic diseases and found a significantly increase of phenylalanine concentration in the blood which indicating PKU. Combined with his typical clinical manifestations of SMA, target capture sequencing followed by Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA) technologies were used for genetic confirmation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>SMA and PKU was confirmed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The child was treated with risdiplam and low phenylalanine formula immediately when he was diagnosed with both SMA and PKU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The child showed remarkable improvement in motor function and significant decrease of blood phenylalanine concentration after treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>To our knowledge, this is the first reported case of SMA combined with PKU. This case expands our understanding of diagnosis for synchronous SMA and PKU and highlights the importance of comprehensive examinations and the utilizing of various genetic testing methods to make an accurate diagnosis of genetic diseases, which may help avoiding the progressive damage caused by certain genetic disease with insidious clinical symptoms.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039076","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:30:48Z","timestamp":1722619848000},"page":"e39076","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Emphasis on the importance of comprehensive clinical and genetic analysis \u2013 spinal muscular atrophy combined with phenylketonuria: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Kai","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6473-5872","authenticated-orcid":false,"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Pediatric Research Institute, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandong","family":"Hu","sequence":"additional","affiliation":[{"name":"Epilepsy Center, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiong","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.braindev.2021.08.002","article-title":"Epidemiological investigation of spinal muscular atrophy in Japan.","volume":"44","author":"Ito","year":"2022","journal-title":"Brain Dev"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening.","volume":"190","author":"Chien","year":"2017","journal-title":"J Pediatr"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"e18975","DOI":"10.1097\/MD.0000000000018975","article-title":"The prevalence of spinal muscular atrophy carrier in China: Evidences from epidemiological surveys.","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"100878","DOI":"10.1016\/j.spen.2021.100878","article-title":"Spinal muscular atrophy.","volume":"37","author":"Nicolau","year":"2021","journal-title":"Semin Pediatr Neurol"},{"key":"R5-20250503","first-page":"2054","article-title":"[Screening of phenylketonuria and analysis of phenylalanine hydroxylase gene in 380 996 newborns from Hainan province].","volume":"100","author":"Zhao","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13023-021-01846-w","article-title":"Neonatal screening and genotype-phenotype correlation of hyperphenylalaninemia in the Chinese population.","volume":"16","author":"Wang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria.","volume":"7","author":"van Spronsen","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1203\/01.PDR.0000141520.06524.51","article-title":"In vivo studies of phenylalanine hydroxylase by phenylalanine breath test: diagnosis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.","volume":"56","author":"Okano","year":"2004","journal-title":"Pediatr Res"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/hmg\/3.4.659","article-title":"Molecular characterization of phenylketonuric mutations in Japanese by analysis of phenylalanine hydroxylase mRNA from lymphoblasts.","volume":"3","author":"Okano","year":"1994","journal-title":"Hum Mol Genet"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/10906570050501461","article-title":"Rapid mutation screening of phenylketonuria by polymerase chain reaction-linked restriction enzyme assay and direct sequence of the phenylalanine hydroxylase gene: clinical application in northern Japan and northern China.","volume":"4","author":"Sueoka","year":"2000","journal-title":"Genet Test"},{"key":"R12-20250503","first-page":"1311","article-title":"Phenylketonuria mutation analysis in Northern Ireland: a rapid stepwise approach.","volume":"57","author":"Zschocke","year":"1995","journal-title":"Am J Hum Genet"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/hmg\/2.10.1703","article-title":"Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe.","volume":"2","author":"Guldberg","year":"1993","journal-title":"Hum Mol Genet"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.gene.2013.05.057","article-title":"Phenylalanine hydroxylase deficiency in the Slovak population: genotype-phenotype correlations and genotype-based predictions of BH4-responsiveness.","volume":"526","author":"Polak","year":"2013","journal-title":"Gene"},{"key":"R15-20250503","first-page":"226","article-title":"[Clinical practice guidelines for phenylketonuria].","volume":"37","author":"Huang","year":"2020","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline.","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet Med"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy.","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"7S9","DOI":"10.1016\/S0929-693X(20)30270-0","article-title":"Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA).","volume":"27","author":"Rouzier","year":"2020","journal-title":"Arch Pediatr"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13023-022-02455-x","article-title":"Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study.","volume":"17","author":"Cances","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41434-022-00349-y","article-title":"Curing SMA: are we there yet?","volume":"30","author":"Reilly","year":"2023","journal-title":"Gene Ther"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S1474-4422(22)00339-8","article-title":"Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.","volume":"21","author":"Masson","year":"2022","journal-title":"Lancet Neurol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria.","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev Neuropsychol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10519-017-9863-1","article-title":"Long-term follow-up of cognition and mental health in adult phenylketonuria: a PKU-COBESO study.","volume":"47","author":"Jahja","year":"2017","journal-title":"Behav Genet"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00431-015-2539-z","article-title":"Mutational spectrum of phenylketonuria in Jiangsu province.","volume":"174","author":"Chen","year":"2015","journal-title":"Eur J Pediatr"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"65ra64","DOI":"10.1126\/scitranslmed.3001756","article-title":"Carrier testing for severe childhood recessive diseases by next-generation sequencing.","volume":"3","author":"Bell","year":"2011","journal-title":"Sci Transl Med"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"R27-20250503","first-page":"3130","article-title":"Medical genetics branch of beijing medical association, Beijing society of rare disease diagnosis and treatment and protection. Expert consensus on the genetic diagnosis of spinal muscular atrophy.","volume":"100","author":"Song","year":"2020","journal-title":"Nat Med J China"},{"key":"R28-20250503","first-page":"1233","article-title":"Genetic diagnosis and analysis of neuromuscular disease pedigree.","volume":"30","author":"Zhang","year":"2022","journal-title":"Chin J Birth Health Heredity"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-0004.1994.tb04002.x","article-title":"Duchenne muscular dystrophy and spinal muscular atrophy type I segregating in the same family.","volume":"45","author":"Oldfors","year":"1994","journal-title":"Clin Genet"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"605611","DOI":"10.3389\/fgene.2021.605611","article-title":"Case report: whole-exome sequencing with MLPA revealed variants in two genes in a patient with combined manifestations of spinal muscular atrophy and duchenne muscular dystrophy.","volume":"12","author":"Xia","year":"2021","journal-title":"Front Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:13:09Z","timestamp":1746317589000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":30,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039076","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}